D
Y-mAbs Therapeutics, Inc. YMAB
$7.08 $0.233.36%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

09/30/2023 06/30/2023 03/31/2023 12/31/2022 09/30/2022
Revenue 20.45M 20.75M 20.25M 31.45M 12.54M
Total Other Revenue -- -- -- -- --
Total Revenue 20.45M 20.75M 20.25M 31.45M 12.54M
Cost of Revenue 2.65M 4.65M 2.08M 2.02M 2.48M
Gross Profit 17.81M 16.10M 18.17M 29.43M 10.06M
SG&A Expenses 10.36M 11.43M 11.40M 385.00K 14.28M
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses -- -- -- -- --
Total Operating Expenses 28.20M 27.97M 23.27M 21.11M 38.55M
Operating Income -7.75M -7.22M -3.02M 10.34M -26.02M
Income Before Tax -7.56M -6.12M -6.39M 1.16M -27.53M
Income Tax Expenses 187.00K 179.00K -- -- --
Earnings from Continuing Operations -7.75M -6.30M -6.39M 1.16M -27.53M
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income -7.75M -6.30M -6.39M 1.16M -27.53M
EBIT -7.75M -7.22M -3.02M 10.34M -26.02M
EBITDA -7.58M -7.00M -2.84M 10.57M -25.79M
EPS Basic -0.18 -0.14 -0.15 0.03 -0.63
Normalized Basic EPS -0.11 -0.09 -0.03 0.20 -0.39
EPS Diluted -0.18 -0.14 -0.15 0.02 -0.63
Normalized Diluted EPS -0.11 -0.09 -0.03 0.20 -0.39
Average Basic Shares Outstanding 43.62M 43.66M 43.67M 43.67M 43.72M
Average Diluted Shares Outstanding 43.62M 43.66M 43.67M 44.69M 43.72M
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --
Weiss Ratings